BRAND NAME:
NOVOSEF INJ. IV 0.5gm
GENERIC NAME:
Ceftriaxone Sodium
DESCRIPTION:
 Ceftriaxone and other third-generation antibiotics are used to treat organisms that tend to be resistant to many other antibiotics
COMPOSITION:
  • Ceftraixone 1gm
  • IntraMascular
INDICATIONS:
  • Meningitis
  • Bone and joint infections
  • Surgical Prophylaxis
  • Typhoid Fever
DOSAGE & ADMINISTRATION:
  • NOVOSEF vials available, containing sterile powder equivalent to 0.25gm, 0.5 g, 1 g of ceftriaxone for IV & .0.5 g for IM administration .
PRESENTATION:
 1 Vail + 10ml Solven
CONTRAINDICATIONS
  •  In patients with known allergy to ceftriaxone other cephalosporins or penicillins.
  • Hyperbilirubinemic neonates and preterm neonates should not be treated with ceftriaxone.
  •  In vitro studies have shown that ceftriaxone can displace bilirubin from its binding to serum albumin and bilirubin encephalopathy can possibly develop in these patients
  •  In neonates Novosef must not be administered concurrently with calcium-containing
    intravenous solutions, including continuous calcium-containing infusions such as parenteral nutrition because of the risk of precipitation of ceftriaxone-calcium salt
UNDESIRABLE EFFECTS
 Although generally well tolerated, the most common adverse reactions associated with ceftriaxone are changes in white blood cell counts, local reactions at site of administration, rash, and diarrhea.
Pack:
 

*Patients should consult with their physician before taking any medicine.

Leave a reply